Lee et al. have demonstrated that c-myc and mitochondrial protein Mcl1 cooperate to activate OXPHOS in breast cancer CSCs, thereby promoting drug resistance and tumor formation [62]. This evidence concerns the gene MCL1 and breast cancer.